Spectral Medical Inc T.EDT

November 14, 2019...Interesting to re-visit some 14 months..

[SouthernTierTom]

later...little has changed, but the 2 FDA approvals, 1 Canada Health approval and $6.5M Baxter arrangement have cost us 1/3 of our share price.  Good ole Stockhouse articles.."Not all is swell at Meddwell" , "Bet the entire company", "Do they have something to hide"?  sigh...not easy holding this gem.  Here is a look back at Novenmber 14 2019 and our special place as the most read bullboard:

Enjoy!  And Kujos to our very own Inspector...you modest lil sleuth...I don't think you ever shared!



Finally we look at a sector where big news can make or break a company’s fortune, the healthcare Bullboards. Spectral Medical Inc. (TSX:EDT, Forum) is all too familiar with how one piece of news can affect a company, as a failed trial for the company’s septic shock treatment in October 2016 sent shares of EDT plummeting, but recently it has climbed in share price and on the most-viewed Bullboards chart.



November has been a good month for Spectral investors. Shares of EDT started the month of November at $0.50 before rocketing up to $0.69 on Nov 6, though it has come back down closer to $0.60 since then. The reason isn’t the company’s PR department, as the latest news release comes from back on Sept. 24 as Spectral announced the launch of a new clinical trial. Instead, it comes from positive initial coverage from an analyst at Paradigm Capital that sees EDT as a buy.

Given positive momentum for the first time in a while, users on the EDT Bullboard were vocally hoping that the company would work to keep the flow going. One potential idea was to get American investors back on board by listing on a higher tier exchange, with Stockhouse Member inspecthrgadget highlighting that Spectral is facing an opportunity to open its doors and continue to climb upwards.

“…The addition of a thorough report from Paradigm is wonderful validation to accompany the message from the company. Looked at Renmark and they have sites all over America to tell the Spectral story. EDT needs to provide a real exchange opportunity for American interest. It was Renmark that moved EDT up a couple tiers on the OTC exchange years back. It was Spectral’s choice to list down on the OTC which prevents news to flow to the US. Hopefully EDT will see the fiduciary light soon...”

(Po?st: RE:New Fodder for Renmark)

[mercedesman]

Berated con-Gag-adulations!  Sadly, I guess our inability to show that we have any impact whatsoever, on the war against Covid has cost us in terms of share price. Just confirmatory, infirmary, and informatory delays ... so far   what would we have done without Baxter's 99 month trickle of reported suppport?  MM   

[inspecthrgadget]

Thanks guys! I did not see that, it was likely a farewell gift from SH. We terminated our SH and Renmark contracts on Oct.31/19. Really a crying $hame as the Paradigm coverage kicked off the next day! Hard to believe the marketing peeps would allow such "Tom-foolery" Sometimes i feel mistakes and blunders could be avoided if not planned FWIW

[SouthernTierTom]

NO worries Gadgie! ....  you know how the septic cookie is made to "crumble" ; - ) Thanks guys! I did not see that, it was likely a farewell gift from SH. We terminated our SH and Renmark contracts on Oct.31/19. Really a crying $hame as the Paradigm coverage kicked off the next day! Hard to believe the marketing peeps would allow such "Tom-foolery" Sometimes i feel